Application 205120
- Type
- ANDA
- Sponsor
- CNTY LINE PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | BUTALBITAL AND ACETAMINOPHEN | ACETAMINOPHEN; BUTALBITAL | TABLET;ORAL | 325MG;50MG | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 47781-535 | Butalbital and Acetaminophen | Butalbital and Acetaminophen | Alvogen, Inc. | ANDA | Current |
| 47781-535 | Butalbital and Acetaminophen | Butalbital and Acetaminophen | Alvogen, Inc. | ANDA | Current |
| 47781-628 | Butalbital and Acetaminophen | Butalbital and Acetaminophen | Alvogen, Inc. | ANDA | Current |
| 47781-628 | Butalbital and Acetaminophen | Butalbital and Acetaminophen | Alvogen, Inc. | ANDA | Current |
| 47781-628 | Butalbital and Acetaminophen | Butalbital and Acetaminophen | Alvogen, Inc. | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 32633 | ORIG | 2015-11-03 |